CRYSTAL L BAKER
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family JOHNSON CITY, NY NPI 1699063198
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family NY Janssen Pharmaceuticals, Inc All categories
General Payments — all program years on this page
$2,599.24
- Category: General Payments
- Program years: PY2021–2024
- Record count: 28
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $780.80 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $780.80 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Pharmaceuticals, Inc | $233.28 | 2 |
| ABBVIE INC. | $191.82 | 2 |
| Otsuka America Pharmaceutical, Inc. | $124.42 | 1 |
| Teva Pharmaceuticals USA, Inc. | $118.05 | 1 |
| Neurocrine BioSciences, Inc. | $113.23 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078110862 | Janssen Pharmaceuticals, Inc | $116.64 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1078110906 | Janssen Pharmaceuticals, Inc | $116.64 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1106472982 | ABBVIE INC. | $125.00 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1106472984 | ABBVIE INC. | $66.82 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1119020190 | Otsuka America Pharmaceutical, Inc. | $124.42 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150924242 | Neurocrine Biosciences, Inc. | $113.23 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151485019 | Teva Pharmaceuticals USA, Inc. | $118.05 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.